Literature DB >> 11805404

Dopamine and male sexual function.

F Giuliano1, J Allard.   

Abstract

The use of the D1/D2 dopamine receptor agonist apomorphine for the treatment of erectile dysfunction provides strong support in favor of a participation of the dopaminergic system in the control of sexual function. However, the exact involvement of dopamine in the control of sexual motivation and genital arousal in males is unknown. Experimental data in male rats suggested an implication of dopamine in sexual motivation as well as in copulatory performance. Specific tests allowing assessment of sexual motivation showed that the release of dopamine at the level of the nucleus accumbens (innervated by the mesolimbic dopaminergic pathway) and the medial preoptic area of the hypothalamus (innervated by the dopaminergic incertohypothalamic pathway) positively regulated the anticipatory/motivational phase of copulatory behavior. A permissive role of dopamine released at the level of the median preoptic area of the hypothalamus in the display of copulatory behavior has also been demonstrated. It is noteworthy that these participations of the dopaminergic system are not specific for sexual behavior but rather reflect the involvement of dopamine in the regulation of cognitive, integrative and reward processes. Because of its role in the control of locomotor activity, the integrity of the nigrostriatal dopaminergic pathway is also essential for the display of copulatory behavior. Somehow more specific to sexual function, it is likely that dopamine can trigger penile erection by acting on oxytocinergic neurons located in the paraventricular nucleus of the hypothalamus, and perhaps on the pro-erectile sacral parasympathetic nucleus within the spinal cord. In conclusion, central dopamine is a key neurotransmitter in the control of sexual function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11805404     DOI: 10.1159/000049844

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  17 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms.

Authors:  Kenneth Blum; Tonia Werner; Stefanie Carnes; Patrick Carnes; Abdalla Bowirrat; John Giordano; Marlene Oscar-Berman; Mark Gold
Journal:  J Psychoactive Drugs       Date:  2012 Jan-Mar

3.  Oxytocin Neurons Enable Melanocortin Regulation of Male Sexual Function in Mice.

Authors:  Erin Semple; Firas Shalabi; Jennifer W Hill
Journal:  Mol Neurobiol       Date:  2019-02-12       Impact factor: 5.590

Review 4.  Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.

Authors:  Abdulmaged M Traish; Irwin Goldstein; Noel N Kim
Journal:  Eur Urol       Date:  2007-02-20       Impact factor: 20.096

5.  Increased accumbens Cdk5 expression in rats after short-access to self-administered cocaine, but not after long-access sessions.

Authors:  Andrew P Seiwell; Maria E Reveron; Christine L Duvauchelle
Journal:  Neurosci Lett       Date:  2007-02-20       Impact factor: 3.046

Review 6.  Sexual dysfunction in the older woman: an overview of the current understanding and management.

Authors:  Kathleen E Walsh; Jennifer R Berman
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Cell-type specific increases in female hamster nucleus accumbens spine density following female sexual experience.

Authors:  Nancy A Staffend; Valerie L Hedges; Benjamin R Chemel; Val J Watts; Robert L Meisel
Journal:  Brain Struct Funct       Date:  2013-08-11       Impact factor: 3.270

8.  Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens.

Authors:  Mehmet Hanifi Tanyeri; Mehmet Emin Buyukokuroglu; Pelin Tanyeri; Oguz Mutlu; Füruzan Yildiz Akar; Güner Ulak; Bekir Faruk Erden
Journal:  Int Urol Nephrol       Date:  2017-07-03       Impact factor: 2.370

Review 9.  Adverse effects of drug therapies on male and female sexual function.

Authors:  Th Stadler; M Bader; S Uckert; M Staehler; A Becker; C G Stief
Journal:  World J Urol       Date:  2006-12       Impact factor: 3.661

10.  Effect of the aqueous extract of the aerial parts of Monsonia angustifolia E. Mey. Ex A. Rich., on the sexual behaviour of male Wistar rats.

Authors:  Gerda Fouche; Anthony J Afolayan; Olubunmi A Wintola; Tendani E Khorombi; Jeremiah Senabe
Journal:  BMC Complement Altern Med       Date:  2015-10-02       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.